foxo4-dri peptide senolytic human trial inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4-DRI: A Breakthrough Peptide Targeting
Pay in 4 interest-free payments of $6.86 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6



























